Immunological recovery and antiretroviral therapy in HIV-1 infection
Top Cited Papers
- 1 May 2006
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 6 (5) , 280-287
- https://doi.org/10.1016/s1473-3099(06)70463-7
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patientsJournal of Clinical Investigation, 2005
- A Prospective, Randomized Trial of Structured Treatment Interruption for Patients with Chronic HIV Type 1 InfectionClinical Infectious Diseases, 2005
- Treatment for Adult HIV InfectionJAMA, 2004
- Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtideAIDS, 2004
- Structured Treatment Interruption in Patients with Multidrug-Resistant Human Immunodeficiency VirusNew England Journal of Medicine, 2003
- Discontinuation of Secondary Prophylaxis for Cryptococcal Meningitis in Human Immunodeficiency Virus–Infected Patients Treated with Highly Active Antiretroviral Therapy: A Prospective, Multicenter, Randomized StudyClinical Infectious Diseases, 2003
- Immune Reconstitution Inflammatory SyndromeMedicine, 2002
- Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?AIDS, 1999
- Discontinuation of Primary Prophylaxis againstPneumocystis cariniiPneumonia in HIV-1–Infected Adults Treated with Combination Antiretroviral TherapyNew England Journal of Medicine, 1999
- Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ countsOphthalmology, 1998